Have a personal or library account? Click to login
Validity, reliability, and sensitivity to change of the Thai version of the Migraine-Specific Quality of Life Questionnaire version 2.1 Cover

Validity, reliability, and sensitivity to change of the Thai version of the Migraine-Specific Quality of Life Questionnaire version 2.1

Asian Biomedicine
Volume 11 (2017): Issue 4 (August 2017)
By: Thanin Asawavichienjinda,  Pongpat Vorasayan,  Jirawadee Noiwattanakul and  Kammant Phanthumchinda  
Open Access
|Mar 2018

References

  1. Headache Classification Committee of the International Headache Society (IHS). The International classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013; 33:629–808.
    Search in Google ScholarBack to article
  2. Dahlöf CG. Measuring disability and quality of life in migraine. Drugs Today (Barc). 2003; 39 Suppl D:17–23.
    Search in Google ScholarBack to article
  3. Freitag FG. The cycle of migraine: patients’ quality of life during and between migraine attacks. Clin Ther. 2007; 29:939–49.1769791310.1016/j.clinthera.2007.05.008
    Open DOISearch in Google ScholarBack to article
  4. Clouse JC, Osterhaus JT. Healthcare resource use and costs associated with migraine in a managed healthcare setting. Ann Pharmacother. 1994; 28:659–64.10.1177/106002809402800518
    Open DOISearch in Google ScholarBack to article
  5. Cavallini A, Micieli G, Bussone G, Rossi F, Nappi G. Headache and quality of life. Headache. 1995; 35:29–35.10.1111/j.1526-4610.1995.hed3501030.x7868331
    Open DOISearch in Google ScholarBack to article
  6. Wagner TH, Patrick DL, Galer BS, Berzon RA. A new instrument to assess the long-term quality of life effects from migraine: development and psychometric testing of the MSQOL. Headache. 1996; 36:484–92.10.1046/j.1526-4610.1996.3608484.x8824004
    Open DOISearch in Google ScholarBack to article
  7. Jhingran P, Osterhaus JT, Miller DW, Lee JT, Kirchdoerfer L. Development and validation of the Migraine-Specific Quality of Life Questionnaire. Headache. 1998; 38:295–302.10.1046/j.1526-4610.1998.3804295.x9595870
    Open DOISearch in Google ScholarBack to article
  8. Kosinski M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH, Batenhorst A, et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res. 2003; 12:963–74.10.1023/A:102611933119314651415
    Open DOISearch in Google ScholarBack to article
  9. Manhalter N, Bozsik G, Palásti A, Csépány E, Ertsey C. The validation of a new comprehensive headache-specific quality of life questionnaire. Cephalalgia. 2012; 32:668–82.10.1177/033310241244770222637722
    Open DOISearch in Google ScholarBack to article
  10. Langeveld JH, Koot HM, Passchier J. Headache intensity and quality of life in adolescents. How are changes in headache intensity in adolescents related to changes in experienced quality of life? Headache. 1997; 37:37–42.
    Search in Google ScholarBack to article
  11. Hartmaier SL, Santanello NC, Epstein RS, Silberstein SD. Development of a brief 24-hour Migraine-Specific Quality of Life Questionnaire. Headache. 1995; 35:320–9.763571710.1111/j.1526-4610.1995.hed3506320.x
    Open DOISearch in Google ScholarBack to article
  12. Jhingran P, Davis SM, LaVange LM, Miller DW, Helms RW. MSQ: migraine-specific quality-of-life questionnaire. Further investigation of the factor structure. Pharmacoeconomics. 1998; 13:707–17.10.2165/00019053-199813060-0000710179706
    Open DOISearch in Google ScholarBack to article
  13. Martin BC, Pathak DS, Sharfman MI, Adelman JU, Taylor F, Kwong WJ, et al. Validity and reliability of the Migraine-Specific Quality of Life Questionnaire (MSQ Version 2.1). Headache. 2000; 40:204–15.10.1046/j.1526-4610.2000.00030.x10759923
    Open DOISearch in Google ScholarBack to article
  14. Pathak D, Martin B, Kwong J, Batenhorst A. Evaluation of the Migraine-Specific Quality of Life Questionnaire (MSQ version 2.0) using confirmatory factor analysis. Qual Life Res. 1998; 7:647.
    Search in Google ScholarBack to article
  15. Bagley CL, Rendas-Baum R, Maglinte GA, Yang M, Varon SF, Lee J, et al. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Headache. 2012; 52:409–21.10.1111/j.1526-4610.2011.01997.x21929662
    Open DOISearch in Google ScholarBack to article
  16. Cole JC, Lin P, Rupnow MF. Validation of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v. 2.1) for patients undergoing prophylactic migraine treatment. Qual Life Res. 2007; 16:1231–7.10.1007/s11136-007-9217-117468941
    Open DOISearch in Google ScholarBack to article
  17. Dodick DW, Silberstein S, Saper J, Freitag FG, Cady RK, Rapoport AM, et al. The impact of topiramate on health-related quality of life indicators in chronic migraine. Headache. 2007; 47:1398–408.10.1111/j.1526-4610.2007.00950.x18052949
    Open DOISearch in Google ScholarBack to article
  18. Silberstein SD, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, et al. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures. Headache. 2009; 49:1153–62.10.1111/j.1526-4610.2009.01508.x
    Open DOISearch in Google ScholarBack to article
  19. Yang M, Rendas-Baum R, Varon SF, Kosinski M. Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine. Cephalalgia. 2011; 31:357–67.2081984210.1177/0333102410379890
    Open DOISearch in Google ScholarBack to article
  20. Rendas-Baum R, Yang M, Varon SF, Bloudek LM, DeGryse RE, Kosinski M. Validation of the Headache Impact Test (HIT-6) in patients with chronic migraine. Health Qual Life Outcomes. 2014; 12:117.10.1186/s12955-014-0117-025080874
    Open DOISearch in Google ScholarBack to article
  21. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, et al. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia. 2007; 27:814–23.10.1111/j.1468-2982.2007.01326.x
    Open DOISearch in Google ScholarBack to article
  22. Cady R, Schreiber C. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Headache. 2008; 48:900–13.1804750110.1111/j.1526-4610.2007.00953.x
    Open DOISearch in Google ScholarBack to article
  23. De Diego EV, Lanteri-Minet M. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT). Cephalalgia. 2005; 25:184–90.10.1111/j.1468-2982.2004.00820.x15689193
    Open DOISearch in Google ScholarBack to article
  24. Nachit-Ouinekh F, Dartigues JF, Henry P, Becg JP, Chastan G, Lemaire N, et al. Use of the headache impact test (HIT-6) in general practice: relationship with quality of life and severity. Eur J Neurol. 2005; 12:189–93.1569380710.1111/j.1468-1331.2004.00934.x
    Open DOISearch in Google ScholarBack to article
  25. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache classification committee of the International Headache Society. Cephalalgia. 1988; 8 Suppl 7:1–96.3048700
    Search in Google ScholarBack to article
  26. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, second edition. Cephalalgia. 2004; 24 Suppl 1:1–160.
    Search in Google ScholarBack to article
  27. Siegel S, Castellan NJ Jr, editors. Nonparametric statistics for the behavioural sciences. 2nd ed. Boston MA: McGraw Hill; 1988, p. 235–44.
    Search in Google ScholarBack to article
  28. Zandifar A, Masjedi SS, Haghdoost F, Asgari F, Manouchehri N, Banihashemi M, et al. The psychometric properties of the Persian Migraine-Specific Quality Of Life Questionnaire version 2.1 in episodic and chronic migraines. Sci World J. 2013; 2013:950245.
    Search in Google ScholarBack to article
  29. Raggi A, Giovannetti AM, Schiavolin S, Leonardi M, Bussone G, Grazzi L, et al. Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse. Qual Life Res. 2014; 23:1273–7.10.1007/s11136-013-0556-924129671
    Open DOISearch in Google ScholarBack to article
  30. Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013; 53:427–36.2347001510.1111/head.12074
    Open DOISearch in Google ScholarBack to article
  31. Kim BK, Chung YK, Kim JM, Lee KS, Chu MK. Prevalence, clinical characteristics and disability of migraine and probable migraine: a nationwide population-based survey in Korea. Cephalalgia. 2013; 33:1106–16.10.1177/0333102413484990
    Open DOISearch in Google ScholarBack to article
  32. Phanthumchinda K, Sithi-Amorn C. Prevalence and clinical features of migraine: a community survey in Bangkok, Thailand. Headache. 1989; 29:594–7.10.1111/j.1526-4610.1989.hed2909594.x
    Open DOISearch in Google ScholarBack to article
  33. Spearman’s correlation Page. [online]. 2016 [cited 2016 Jun 22]. Available from: http://www.statstutor.ac.uk/resources/uploaded/spearmans.pdf
    Search in Google ScholarBack to article
  34. George D, Mallery P, editors. SPSS for Windows step by step: a simple guide and reference (11.0 update). 4th ed. Boston: Allyn and Bacon; 2003.
    Search in Google ScholarBack to article
  35. Silberstein SD. Preventive migraine treatment. Continuum (Minneap Minn). 2015; 21:973–89.26252585
    Search in Google ScholarBack to article
  36. Silberstein SD. Topiramate in migraine prevention: a 2016 perspective. Headache. 2017; 57:165–78.10.1111/head.1299727902848
    Open DOISearch in Google ScholarBack to article
DOI: https://doi.org/10.1515/abm-2018-0005 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Journal RSS Feed
Language: English
Page range: 331 - 342
Published on: Mar 21, 2018
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
health-related quality of life,
Migraine-Specific Quality of Life Questionnaire version 2.1,
reliability,
sensitivity to change,
Thai version of the MSQv2.1,
validity
Related subjects:
Medicine,
Assistive professions, nursing,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Clinical medicine, other

© 2018 Thanin Asawavichienjinda, Pongpat Vorasayan, Jirawadee Noiwattanakul, Kammant Phanthumchinda, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 11 (2017): Issue 4 (August 2017)Next article